IND-enabling services

It is crucial to have access to quick and reliable bioanalytical services for the successful development and commercialization of a new drug/therapeutic. TME is dedicated to providing highly comprehensive in-vivo Investigational New Drug (IND)-enabling services for the effective evaluation of your drug and helping you through all the phases of drug development. Our experienced team is abreast with the ever-changing regulatory environment and provides the necessary methodology and experimental support to expedite the drug development process.

Services include
  • Specimen analysis for preclinical and clinical trials
  • Drug profiles and administration route
  • Bioanalysis
  • PK assay
  • Toxicity and drug safety analysis
  • Bioavailability & bioequivalence studies
  • Metabolite and biomarker screening
  • GLP method development & validation
Talk to our experts for customized solutions